René is one of the world’s leading scientists in biotechnology. He holds a doctorate in chemistry from University of Berne in Switzerland. He is a co-founder and executive of FGen, a biotechnology spin-off of the ETH Zürich, that developed the nanoliter reactor (NLR) research methodology. In 2022, FGen was bought by US-based Ginkgo Bioworks. René has over 20 years of experience in management and has extensive knowledge of the commercial side of biotechnology.
René Pellaux
Advisor
Personal interest:
René loves sailing the oceans, especially the Caribbean, exploring unknown nature and cultures and testing the elements of water and wind. This is a good counterbalance to the complex day-to-day work of a biotechnologist. When on solid ground, René also likes to taste wine and work on his oenology skills.
René’s home base is Zürich (Switzerland).
